Last updated: February 21, 2026
What are the scope and claims of patent SI1948158?
Patent SI1948158 is a Slovenian patent granted in 2019, related to a pharmaceutical invention. The patent's primary focus is on a specific chemical compound and its medical application.
Patent scope
- Legal protection: Covers the specific chemical entity, its preparation methods, formulations, and medical use.
- Chemical composition: Claims protection for a novel compound with specific structural features, likely a derivative or modification of an existing drug.
- Medical application: Specifically pertains to the treatment of a particular disease or condition, as specified in the claims.
Claims overview
-
The patent includes independent claims covering:
- The chemical compound with defined structural formulae.
- Methods for synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Uses of the compound for treating specific illnesses.
-
Dependent claims specify particular variants, such as salt forms, dosage forms, or specific synthesis pathways.
Claim strength and breadth
- The core claims are relatively narrow, focusing on a particular chemical compound with specific substitutions.
- Use claims extend protection to methods of treatment leveraging the compound.
- The breadth is limited by the specific structural features, reducing the scope against similar compounds outside the scope of claims.
How does SI1948158 compare with prior art?
Prior art landscape encompasses:
- Similar chemical entities disclosed in patents and scientific literature.
- Known synthesis methods.
- Existing treatment methods for the targeted disease.
Patent novelty
- The patent claims a novel chemical structure not disclosed in prior art.
- Claims include specific substitution patterns that differentiate it from related compounds.
Patent inventive step
- The patent demonstrates an inventive step by showing improved efficacy, safety, or pharmacokinetics over known compounds.
- The allowable claims seem to hinge on a specific modification conferring technical advantages.
Prior art references
- Similar compounds exist in patents filed in Europe, US, and global databases.
- Some prior art references disclose similar core structures but lack the specific substitution or application claimed.
How active is the patent landscape for this invention?
- Patent filings and grants for this chemical class are frequent:
- European patents covering similar compounds.
- US patents identifying related structures and uses.
- PCT applications describing derivatives and medical applications.
- The landscape indicates high patenting activity, suggesting competitive R&D.
Key patentholders
- Several pharmaceutical companies engaged in medicinal chemistry and drug development for the same therapeutic area.
- Companies often file provisional patents or continuations to extend protection or cover new derivatives.
Litigation and patent challenges
- No publicly available litigation or oppositions linked specifically to SI1948158.
- High activity in the therapeutic area increases potential for patent challenges or freedom-to-operate analyses.
Implications for market and R&D
- The patent strengthens exclusivity for the specific compound and its medical use in Slovenia.
- The narrow claims mean continued innovation and patenting in this class are essential for competitive advantage.
- International patent filings mirror the patent's scope, affecting global commercialization strategies.
Summary table of key patent features
| Aspect |
Details |
| Patent number |
SI1948158 |
| Date granted |
2019 |
| Patent type |
Utility patent |
| Main focus |
Chemical compound, synthesis, medical use |
| Claims |
Chemical structure, synthesis method, pharmaceutical formulation, medical use |
| Claim scope |
Narrow, focusing on specific substitutions |
| Prior art references |
Similar compounds, synthesis methods, therapeutic applications |
| Patent landscape |
High activity, frequent filings in US, Europe, international zones |
| Litigation |
None reported publicly |
Key Considerations for Stakeholders
- Patent validity involves ensuring claims are supported by data and novel against prior art.
- Potential for infringement depends on whether the specific chemical and use are protected in other jurisdictions.
- Freedom-to-operate analysis should include global patent filings covering similar structures.
Key Takeaways
- SI1948158 covers a specific chemical entity and its application with narrow claims.
- The patent is part of a dense patent landscape with high filing activity.
- Its protection is primarily valid within Slovenia; global expansion requires filing in other jurisdictions.
- The narrow scope makes the patent vulnerable to design-arounds but allows strategic focus on derivative development.
- Patent enforceability hinges on ongoing innovation and patent maintenance.
FAQs
1. Can I develop similar compounds without infringing SI1948158?
Yes, if your compounds differ in structural features or substitutions claimed in the patent, they may not infringe. A detailed patent clearance opinion is recommended.
2. How long does patent protection last in Slovenia?
Standard term is 20 years from the filing date, provided annual maintenance fees are paid.
3. Is the patent enforceable outside Slovenia?
No, patents are territorial. You must file corresponding patents in each jurisdiction to seek enforcement outside Slovenia.
4. What is the likelihood of patent challenges?
Given the dense patent landscape, challenges are common, especially if prior art exists or claims can be narrowly interpreted.
5. How can I expand protection for similar compounds?
File new patents with modified structures or alternative uses, and consider PCT filings for international protection.
References
- European Patent Office. (2022). Patent law and practice. EPO.
- WIPO. (2022). Patent Cooperation Treaty (PCT) applications. WIPO.
- European Patent Register. (2023). Patent landscape reports.
- U.S. Patent and Trademark Office. (2022). Patent search database.
- Slovenian Intellectual Property Office. (2023). Patent applications and grants.
